Biotech plays, with Jason Zhang, biotech analyst at BMO, and Christopher Raymond, biotech analyst at Robert W. Baird & Co.
A look at the biotech company in Iceland that has made discoveries about genes for common conditions like heart disease, stroke and cancer, ...
A new study identifies a potential cancer risk in certain Vytoriin patients, reports CNBC's Mike Huckman
Vytorin did not meet main goals in new study, reports CNBC's Mike Huckman
A look at the biotech company's Q2 results, with Christopher Raymond, Robert W. Baird & Co. senior biotech analyst
Posts |
TOPIC : Biotechnology
22 Jul 2008
Why's the market up after such horrible earnings? Black gold, that's why.... Read More
21 Jul 2008
Cramer ventures a guess as to who's next on the takeover list.... Read More
7 Jul 2008
On tonight's show we came back to one of my favorite themes, that the idea of "the market" is at best unhelpful.... Read More
7 Jul 2008
Cramer continued with his "Cramerican Marine Field Guide to Recessions" reflecting on the 1990 Playbook (the last time we had a financial meltdown) where healthcare stocks, especially biotech were the winners then, and in Cramer's view are likely to do it again.... Read More
7 Jul 2008
Cramer tells what works in the Wall Street fashion show, what gets the big money guys to turn their heads and say, “ah, I want to own that right now,” or "I want to dump that right now", for the exact... Read More
News |
TOPIC : Biotechnology
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes